TY - JOUR
T1 - Coverage and Cost-of-Care Links
T2 - Addressing Financial Toxicity Among Patients With Hematologic Cancer and Their Caregivers
AU - Edward, Jean S.
AU - McLouth, Laurie E.
AU - Rayens, Mary Kay
AU - Eisele, Lori P.
AU - Davis, Tani S.
AU - Hildebrandt, Gerhard
N1 - Publisher Copyright:
© American Society of Clinical Oncology.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - PURPOSEThis study examined the feasibility, acceptability, and preliminary effectiveness of an oncology financial navigation (OFN) intervention, Coverage and Cost-of-Care Links (CC Links), among patients with hematologic cancer and their caregivers who are at increased risk of experiencing financial toxicity (FT).METHODSAll patients who presented to the Division of Hematology and Bone and Marrow Transplant (BMT) at an National Cancer Institute-designated cancer center between April 2021 and January 2022 were screened for FT during inpatient and outpatient visits. Patients who screened positive for FT and met the inclusion criteria were recruited to participate in CC Links that provided financial navigation and assistance via a financial navigator. Caregivers of patients undergoing BMTs were also recruited to participate. Primary outcomes were defined as improvements in FT, distress, and physical and mental quality of life.RESULTSFifty-four patients and 32 caregivers completed the intervention and pre-/postintervention surveys. CC Links resulted in statistically significant decreases in the Comprehensive Score for FT for both patients (|t| = 2.42, P =.019) and caregivers (|t| = 2.43, P =.021) and total FT (|t| = 2.13, P =.041) and material conditions scores (|t| = 2.25, P =.031) for caregivers only. Only 27% of eligible patients participated in the study, whereas 100% of eligible caregivers participated. The majority of participants rated the intervention highly for acceptability (89%) and appropriateness (88%). An average of $2,500 (USD) in financial benefits was secured per participant via CC Links.CONCLUSIONCC Links was effective in decreasing FT among patients with hematologic cancer and their caregivers while demonstrating high acceptability and appropriateness ratings.
AB - PURPOSEThis study examined the feasibility, acceptability, and preliminary effectiveness of an oncology financial navigation (OFN) intervention, Coverage and Cost-of-Care Links (CC Links), among patients with hematologic cancer and their caregivers who are at increased risk of experiencing financial toxicity (FT).METHODSAll patients who presented to the Division of Hematology and Bone and Marrow Transplant (BMT) at an National Cancer Institute-designated cancer center between April 2021 and January 2022 were screened for FT during inpatient and outpatient visits. Patients who screened positive for FT and met the inclusion criteria were recruited to participate in CC Links that provided financial navigation and assistance via a financial navigator. Caregivers of patients undergoing BMTs were also recruited to participate. Primary outcomes were defined as improvements in FT, distress, and physical and mental quality of life.RESULTSFifty-four patients and 32 caregivers completed the intervention and pre-/postintervention surveys. CC Links resulted in statistically significant decreases in the Comprehensive Score for FT for both patients (|t| = 2.42, P =.019) and caregivers (|t| = 2.43, P =.021) and total FT (|t| = 2.13, P =.041) and material conditions scores (|t| = 2.25, P =.031) for caregivers only. Only 27% of eligible patients participated in the study, whereas 100% of eligible caregivers participated. The majority of participants rated the intervention highly for acceptability (89%) and appropriateness (88%). An average of $2,500 (USD) in financial benefits was secured per participant via CC Links.CONCLUSIONCC Links was effective in decreasing FT among patients with hematologic cancer and their caregivers while demonstrating high acceptability and appropriateness ratings.
UR - http://www.scopus.com/inward/record.url?scp=85159543982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159543982&partnerID=8YFLogxK
U2 - 10.1200/OP.22.00665
DO - 10.1200/OP.22.00665
M3 - Article
C2 - 36888937
AN - SCOPUS:85159543982
SN - 2688-1527
VL - 19
SP - E696-E705
JO - JCO Oncology Practice
JF - JCO Oncology Practice
IS - 5
ER -